Johnson And Johnson Vaccine
-
{
- All
- News
- Videos
-
US Limits Johnson & Johnson Covid Vaccine Use Over Rare Blood Clot Risk
The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition.
-
Johnson & Johnson Forecasts $2.5 Billion In COVID-19 Vaccine Sales
Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns.
-
US Looking At Joint Production Of Johnson And Johnson's In India
The US is looking at joint production of Johnson and Johnson's COVID-19 vaccine in India and ways to help manufacturers like the Serum Institute of India (SII) to boost production, Daniel B Smith, the Charge D'Affaires of the US embassy, said on Tues
-
Johnson & Johnson Starts Human Trial For Its COVID-19 Vaccine Candidate
Johnson & Johnson on Thursday kicked off US human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.
-
US Limits Johnson & Johnson Covid Vaccine Use Over Rare Blood Clot Risk
The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition.
-
Johnson & Johnson Forecasts $2.5 Billion In COVID-19 Vaccine Sales
Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns.
-
US Looking At Joint Production Of Johnson And Johnson's In India
The US is looking at joint production of Johnson and Johnson's COVID-19 vaccine in India and ways to help manufacturers like the Serum Institute of India (SII) to boost production, Daniel B Smith, the Charge D'Affaires of the US embassy, said on Tues
-
Johnson & Johnson Starts Human Trial For Its COVID-19 Vaccine Candidate
Johnson & Johnson on Thursday kicked off US human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.
